2-178756224-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001267550.2(TTN):​c.11252G>A​(p.Gly3751Asp) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.9 in 1,594,874 control chromosomes in the GnomAD database, including 650,799 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/17 in silico tools predict a benign outcome for this variant. 2/2 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G3751E) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.87 ( 58115 hom., cov: 33)
Exomes 𝑓: 0.90 ( 592684 hom. )

Consequence

TTN
NM_001267550.2 missense, splice_region

Scores

1
2
10
Splicing: ADA: 0.002052
1

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 3.78

Publications

34 publications found
Variant links:
Genes affected
TTN (HGNC:12403): (titin) This gene encodes a large abundant protein of striated muscle. The product of this gene is divided into two regions, a N-terminal I-band and a C-terminal A-band. The I-band, which is the elastic part of the molecule, contains two regions of tandem immunoglobulin domains on either side of a PEVK region that is rich in proline, glutamate, valine and lysine. The A-band, which is thought to act as a protein-ruler, contains a mixture of immunoglobulin and fibronectin repeats, and possesses kinase activity. An N-terminal Z-disc region and a C-terminal M-line region bind to the Z-line and M-line of the sarcomere, respectively, so that a single titin molecule spans half the length of a sarcomere. Titin also contains binding sites for muscle associated proteins so it serves as an adhesion template for the assembly of contractile machinery in muscle cells. It has also been identified as a structural protein for chromosomes. Alternative splicing of this gene results in multiple transcript variants. Considerable variability exists in the I-band, the M-line and the Z-disc regions of titin. Variability in the I-band region contributes to the differences in elasticity of different titin isoforms and, therefore, to the differences in elasticity of different muscle types. Mutations in this gene are associated with familial hypertrophic cardiomyopathy 9, and autoantibodies to titin are produced in patients with the autoimmune disease scleroderma. [provided by RefSeq, Feb 2012]
TTN-AS1 (HGNC:44124): (TTN antisense RNA 1) This gene encodes a non-coding RNA transcribed from the opposite strand to the titin gene. [provided by RefSeq, Aug 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=8.103962E-7).
BP6
Variant 2-178756224-C-T is Benign according to our data. Variant chr2-178756224-C-T is described in ClinVar as [Benign]. Clinvar id is 47852.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.925 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TTNNM_001267550.2 linkc.11252G>A p.Gly3751Asp missense_variant, splice_region_variant Exon 46 of 363 ENST00000589042.5 NP_001254479.2 A0A0A0MTS7
TTNNM_133379.5 linkc.10303+2760G>A intron_variant Intron 44 of 45 ENST00000360870.10 NP_596870.2 Q8WZ42-6Q7Z3B7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TTNENST00000589042.5 linkc.11252G>A p.Gly3751Asp missense_variant, splice_region_variant Exon 46 of 363 5 NM_001267550.2 ENSP00000467141.1 A0A0A0MTS7
TTNENST00000360870.10 linkc.10303+2760G>A intron_variant Intron 44 of 45 5 NM_133379.5 ENSP00000354117.4 Q8WZ42-6

Frequencies

GnomAD3 genomes
AF:
0.870
AC:
132390
AN:
152096
Hom.:
58094
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.835
Gnomad AMI
AF:
0.952
Gnomad AMR
AF:
0.719
Gnomad ASJ
AF:
0.918
Gnomad EAS
AF:
0.781
Gnomad SAS
AF:
0.791
Gnomad FIN
AF:
0.890
Gnomad MID
AF:
0.949
Gnomad NFE
AF:
0.931
Gnomad OTH
AF:
0.895
GnomAD2 exomes
AF:
0.838
AC:
203686
AN:
242962
AF XY:
0.850
show subpopulations
Gnomad AFR exome
AF:
0.839
Gnomad AMR exome
AF:
0.570
Gnomad ASJ exome
AF:
0.913
Gnomad EAS exome
AF:
0.755
Gnomad FIN exome
AF:
0.891
Gnomad NFE exome
AF:
0.930
Gnomad OTH exome
AF:
0.869
GnomAD4 exome
AF:
0.903
AC:
1303069
AN:
1442660
Hom.:
592684
Cov.:
30
AF XY:
0.902
AC XY:
644760
AN XY:
714838
show subpopulations
African (AFR)
AF:
0.833
AC:
27515
AN:
33034
American (AMR)
AF:
0.585
AC:
25739
AN:
44034
Ashkenazi Jewish (ASJ)
AF:
0.917
AC:
23445
AN:
25568
East Asian (EAS)
AF:
0.783
AC:
30835
AN:
39368
South Asian (SAS)
AF:
0.796
AC:
67445
AN:
84726
European-Finnish (FIN)
AF:
0.888
AC:
46283
AN:
52120
Middle Eastern (MID)
AF:
0.929
AC:
5283
AN:
5688
European-Non Finnish (NFE)
AF:
0.931
AC:
1023189
AN:
1098588
Other (OTH)
AF:
0.896
AC:
53335
AN:
59534
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.462
Heterozygous variant carriers
0
5472
10943
16415
21886
27358
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21406
42812
64218
85624
107030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.870
AC:
132452
AN:
152214
Hom.:
58115
Cov.:
33
AF XY:
0.865
AC XY:
64327
AN XY:
74408
show subpopulations
African (AFR)
AF:
0.834
AC:
34652
AN:
41528
American (AMR)
AF:
0.718
AC:
10974
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.918
AC:
3189
AN:
3472
East Asian (EAS)
AF:
0.781
AC:
4039
AN:
5174
South Asian (SAS)
AF:
0.791
AC:
3810
AN:
4816
European-Finnish (FIN)
AF:
0.890
AC:
9448
AN:
10612
Middle Eastern (MID)
AF:
0.949
AC:
279
AN:
294
European-Non Finnish (NFE)
AF:
0.931
AC:
63300
AN:
68022
Other (OTH)
AF:
0.897
AC:
1895
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
860
1720
2579
3439
4299
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
894
1788
2682
3576
4470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.909
Hom.:
281364
Bravo
AF:
0.854
TwinsUK
AF:
0.931
AC:
3453
ALSPAC
AF:
0.930
AC:
3584
ESP6500AA
AF:
0.840
AC:
3266
ESP6500EA
AF:
0.932
AC:
7723
ExAC
AF:
0.849
AC:
102606
Asia WGS
AF:
0.795
AC:
2768
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:7
Jan 31, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Sep 16, 2011
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 09, 2025
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 24, 2013
Biesecker Lab/Clinical Genomics Section, National Institutes of Health
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Dec 18, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive limb-girdle muscular dystrophy type 2J;C1858763:Dilated cardiomyopathy 1G Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.67
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
17
DANN
Benign
0.91
Eigen
Uncertain
0.34
Eigen_PC
Uncertain
0.35
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Benign
0.43
T;T
MetaRNN
Benign
8.1e-7
T;T
MetaSVM
Benign
-1.0
T
PhyloP100
3.8
PROVEAN
Benign
-0.84
.;N
REVEL
Benign
0.037
Sift
Benign
1.0
.;T
Vest4
0.14
MPC
0.11
ClinPred
0.014
T
GERP RS
4.2
Mutation Taster
=45/55
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0021
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7585334; hg19: chr2-179620951; COSMIC: COSV107410183; COSMIC: COSV107410183; API